Combination injectable therapy for type 2 diabetes. Contains a higher dose of insulin glargine and lixisenatide. Provides enhanced blood sugar control./Description: Soliqua Solostar 50 mcg 3×3 ml is a pre-filled insulin pen combining a higher dose of insulin glargine, a long-acting basal insulin, with lixisenatide, a GLP-1 receptor agonist. It is used to improve blood glucose control in adults with type 2 diabetes inadequately controlled by basal insulin or GLP-1 therapy alone. Soliqua 50 mcg formulation delivers a stronger dose per injection for patients requiring greater glycemic management. It works by stimulating insulin secretion, reducing liver sugar production, and slowing gastric emptying. Administered once daily, it offers a convenient and effective way to stabilize blood sugar. It should only be used under medical supervision with proper dose adjustment.. Please Note that product description, color, ingredients, package and other information maybe different from the original pack kindly check the product for more accurate details.
